Pulmonary vascular disease

Pulmonary vascular disease

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
Matthias Ebner, Niklas Guddat, Karsten Keller, Marie Christine Merten, Markus H. Lerchbaumer, Gerd Hasenfuß, Stavros V. Konstantinides, Mareike Lankeit

ERJ Open Research Oct 2020, 6 (4) 00625-2020; DOI: 10.1183/23120541.00625-2020
Importance of computed tomography in defining segmental disease in chronic thromboembolic pulmonary hypertension
Micheal C. McInnis, David Wang, Laura Donahoe, John Granton, John Thenganatt, Kongteng Tan, John Kavanagh, Marc de Perrot

ERJ Open Research Oct 2020, 6 (4) 00461-2020; DOI: 10.1183/23120541.00461-2020
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Barbro Kjellström, Anna Sandqvist, Clara Hjalmarsson, Magnus Nisell, Per Näsman, Bodil Ivarsson

ERJ Open Research Oct 2020, 6 (4) 00299-2020; DOI: 10.1183/23120541.00299-2020
Socioeconomic status and survival in patients with pulmonary hypertension
Mei-Sing Ong

ERJ Open Research Oct 2020, 6 (4) 00638-2020; DOI: 10.1183/23120541.00638-2020
Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease
Michael McGettrick, Paul McCaughey, Alexander MacLellan, Melanie Brewis, A. Colin Church, Martin K. Johnson

ERJ Open Research Oct 2020, 6 (4) 00297-2019; DOI: 10.1183/23120541.00297-2019
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Catharina Belge, Rozenn Quarck, Laurent Godinas, David Montani, Pilar Escribano Subias, Jean-Luc Vachiéry, Heba Nashat, Joanna Pepke-Zaba, Marc Humbert, Marion Delcroix

ERJ Open Research Oct 2020, 6 (4) 00520-2020; DOI: 10.1183/23120541.00520-2020
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
Steffen D. Kriechbaum, Lillith Scherwitz, Christoph B. Wiedenroth, Felix Rudolph, Jan-Sebastian Wolter, Moritz Haas, Ulrich Fischer-Rasokat, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Stefan Guth, Till Keller, Stavros V. Konstantinides, Mareike Lankeit, Christoph Liebetrau

ERJ Open Research Oct 2020, 6 (4) 00356-2020; DOI: 10.1183/23120541.00356-2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly
Sheila Ramjug, Jason Weatherald, Sandeep Sahay, Johad Khoury, Vasile Foris, Nagaraj Chandran, Aleksandar Bokan, Laurent Godinas, Marion Delcroix

ERJ Open Research Oct 2020, 6 (4) 00304-2020; DOI: 10.1183/23120541.00304-2020
Pulmonary arterial hypertension-associated changes in gut pathology and microbiota
Ravindra K. Sharma, Aline C. Oliveira, Tao Yang, Seungbum Kim, Jasenka Zubcevic, Victor Aquino, Gilberto O. Lobaton, Ruby Goel, Elaine M. Richards, Mohan K. Raizada

ERJ Open Research Jul 2020, 6 (3) 00253-2019; DOI: 10.1183/23120541.00253-2019
Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
Godsfavour Umoru, Matthew Taitano, Sarah Beshay, Polly Niravath, Sandeep Sahay

ERJ Open Research Apr 2020, 6 (2) 00199-2020; DOI: 10.1183/23120541.00199-2020

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us